<DOC>
	<DOCNO>NCT00676312</DOCNO>
	<brief_summary>This study design investigate safety tolerability PTH134 healthy subject assess exposure PTH134 .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetic Pharmacodynamic Effect PTH134 Increasing Doses Healthy Postmenopausal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<criteria>Healthy postmenopausal female subject , 40 70 year age good health determine past medical history , physical examination , vital sign , electrocardiogram , laboratory test screen Body mass index ( BMI ) within range 19 32 . Smokers report cigarette use &gt; = 5 cigarette per day . Use prescription drug overthecounter ( OTC ) medication ( vitamin , herbal supplement , dietary supplement ) start within last month prior screen . Previous osteoporosis treatment History drug alcohol abuse within 12 month prior dose evidence abuse Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>parathyroid hormone</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>